Loading stock data…
$1.02
Microbot Medical Inc.
Microbot Medical Inc. in the Healthcare sector is trading at $1.02 with a market capitalization of $101M. Wall Street consensus targets $6.33 (3 analysts), implying a +520.9% move over the next 12 months. The stock is currently near its 52-week low of $1.00, remaining 46.6% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 13 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $105,000 | $0 | $0 | $0 |
| Gross Profit | — | $2,000 | — | — | — |
| Operating Income | — | -$4.32M↓ | -$4.14M↓ | -$3.86M↓ | -$3.72M |
| Net Income | — | -$3.67M↓ | -$3.46M↑ | -$3.58M↓ | -$3.50M |
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical sy...